Related Experiment Video
Updated: Apr 7, 2026
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
4.5K
[Interventions at the tricuspid valve: What is possible?]
Alexander Lauten1, H-R Figulla
1Medizinische Klinik für Kardiologie, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Deutschland, alexander.lauten@charite.de.
Herz
|July 3, 2015
Summary
Tricuspid regurgitation (TR) presents challenges for transcatheter treatment due to the dynamic tricuspid annulus. Novel interventional approaches are emerging for TR, offering potential future therapeutic options.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Context:
- Increasing life expectancy and improved cardiac treatments highlight tricuspid valve disease as an emerging interventional target.
- Tricuspid stenosis is rare and treatable with balloon valvuloplasty, but tricuspid regurgitation (TR) lacks established transcatheter solutions.
- The dynamic and complex nature of the tricuspid annulus complicates long-term fixation of transcatheter valves.
Purpose:
- To review the current landscape and future directions for interventional treatment of tricuspid regurgitation (TR).
- To discuss the challenges associated with transcatheter approaches for TR.
- To explore alternative and emerging therapeutic strategies for TR.
Summary:
- No effective transcatheter approach for tricuspid regurgitation (TR) is currently established.
- Transcatheter caval valve implantation (CAVI) shows promise for managing TR by addressing caval vein regurgitation.
- Tricuspid valve repair techniques, such as annular plication using devices like Mitralign™ and TriCinch™, are under investigation.
Impact:
- Development of percutaneous systems and therapies for tricuspid regurgitation is anticipated in the medium term.
- Clinical studies will be crucial to validate the functional and prognostic effects of these novel TR treatments.
- Advances in interventional cardiology aim to provide effective solutions for previously untreatable tricuspid valve diseases.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
586
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
586
01:28Mitral Regurgitation IV: Nursing Management
539
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
539
01:26Mitral Stenosis III: Medical Management
475
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
475
01:16Heart Valves
15.2K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
15.2K
01:17Aortic Regurgitation IV: Nursing Management
410
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
410
01:22Mitral Valve Prolapse II: Assessment and Management
1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K